328 related articles for article (PubMed ID: 23403423)
1. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.
Tejman-Yarden N; Miyamoto Y; Leitsch D; Santini J; Debnath A; Gut J; McKerrow JH; Reed SL; Eckmann L
Antimicrob Agents Chemother; 2013 May; 57(5):2029-35. PubMed ID: 23403423
[TBL] [Abstract][Full Text] [Related]
2. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Leitsch D
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram.
Galkin A; Kulakova L; Lim K; Chen CZ; Zheng W; Turko IV; Herzberg O
J Biol Chem; 2014 Apr; 289(15):10502-10509. PubMed ID: 24558036
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel antigiardiasis drug candidates.
Kulakova L; Galkin A; Chen CZ; Southall N; Marugan JJ; Zheng W; Herzberg O
Antimicrob Agents Chemother; 2014 Dec; 58(12):7303-11. PubMed ID: 25267663
[TBL] [Abstract][Full Text] [Related]
5. Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases.
Debnath A; Ndao M; Reed SL
Gut Microbes; 2013; 4(1):66-71. PubMed ID: 23137963
[TBL] [Abstract][Full Text] [Related]
6. Viability Screen of LOPAC
Yason JA; Koh KARP; Tan KSW
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866860
[No Abstract] [Full Text] [Related]
7. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
Lemée V; Zaharia I; Nevez G; Rabodonirina M; Brasseur P; Ballet JJ; Favennec L
J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206
[TBL] [Abstract][Full Text] [Related]
8. Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis.
Escrig JI; Miyamoto Y; Aznar AD; Eckmann L; Debnath A
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0073123. PubMed ID: 38063401
[TBL] [Abstract][Full Text] [Related]
9. Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.
Capparelli EV; Bricker-Ford R; Rogers MJ; McKerrow JH; Reed SL
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821451
[TBL] [Abstract][Full Text] [Related]
10. Physiological aspects of nitro drug resistance in Giardia lamblia.
Müller J; Hemphill A; Müller N
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):271-277. PubMed ID: 29738984
[TBL] [Abstract][Full Text] [Related]
11. Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.
Kim WJ; Korthals KA; Li S; Le C; Kalisiak J; Sharpless KB; Fokin VV; Miyamoto Y; Eckmann L
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396548
[No Abstract] [Full Text] [Related]
12. Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target.
Leitsch D; Müller J; Müller N
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):148-153. PubMed ID: 27485086
[TBL] [Abstract][Full Text] [Related]
13. Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Reyes-Vivas H; de la Mora-de la Mora I; Castillo-Villanueva A; Yépez-Mulia L; Hernández-Alcántara G; Figueroa-Salazar R; García-Torres I; Gómez-Manzo S; Méndez ST; Vanoye-Carlo A; Marcial-Quino J; Torres-Arroyo A; Oria-Hernández J; Gutiérrez-Castrellón P; Enríquez-Flores S; López-Velázquez G
Antimicrob Agents Chemother; 2014 Dec; 58(12):7072-82. PubMed ID: 25223993
[TBL] [Abstract][Full Text] [Related]
14. Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.
Tejman-Yarden N; Millman M; Lauwaet T; Davids BJ; Gillin FD; Dunn L; Upcroft JA; Miyamoto Y; Eckmann L
Antimicrob Agents Chemother; 2011 Oct; 55(10):4643-51. PubMed ID: 21825286
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
Ribeiro MRS; Oliveira DR; Caliari MV; Cara Machado DC; Andrade MER; Cardoso VN; Dos Santos Martins F; Nicoli JR; Gomes MA
J Appl Microbiol; 2021 Jul; 131(1):460-469. PubMed ID: 33289232
[TBL] [Abstract][Full Text] [Related]
16. Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization.
Busatti HG; Alves RJ; Santana-Anjos KG; Gil FF; Cury MC; Vannier-Santos MA; Gomes MA
Diagn Microbiol Infect Dis; 2013 Feb; 75(2):160-4. PubMed ID: 23331963
[TBL] [Abstract][Full Text] [Related]
17. Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs.
Nillius D; Müller J; Müller N
J Antimicrob Chemother; 2011 May; 66(5):1029-35. PubMed ID: 21393225
[TBL] [Abstract][Full Text] [Related]
18. Giardiasis: a pharmacotherapy review.
Escobedo AA; Cimerman S
Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
[TBL] [Abstract][Full Text] [Related]
19. Promising effects of 1,8 Cineole to control Giardia lamblia infection: Targeting the inflammation, oxidative stress, and infectivity.
Masoori L; Khalaf AK; Ezzatkhah F; Balaña-Fouce R; Mahmoudvand H
Acta Trop; 2024 Jul; 255():107201. PubMed ID: 38604329
[TBL] [Abstract][Full Text] [Related]
20.
Morales-Luna L; Hernández-Ochoa B; Martínez-Rosas V; Navarrete-Vázquez G; Ortega-Cuellar D; Rufino-González Y; González-Valdez A; Arreguin-Espinosa R; Franco-Vásquez AM; Pérez de la Cruz V; Enríquez-Flores S; Martínez-Conde C; Canseco-Ávila LM; Gómez-Chávez F; Gómez-Manzo S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
